Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the disease. Here, we...
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
American Chemical Society
2020
|